{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T01:49:17Z","timestamp":1794620957812,"version":"4.9.1"},"reference-count":21,"publisher":"American Academy of Pediatrics (AAP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,4,1]]},"abstract":"<jats:sec>\n                  <jats:title>BACKGROUND<\/jats:title>\n                  <jats:p>Community-acquired pneumonia (CAP) is common in pediatrics. More severe complicated CAP (cCAP) requires broad-spectrum empirical therapy. Cell-free plasma next-generation sequencing (cfNGS), a DNA-based diagnostic tool, could be used to guide therapy. We retrospectively compared the pathogen identification rate of cfNGS to that of standard culture methods and assessed the impact of cfNGS on antibiotic therapy in children hospitalized for cCAP.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS<\/jats:title>\n                  <jats:p>We conducted a retrospective review of children aged 3 months to 18 years hospitalized for cCAP with cfNGS results from January 24, 2018, to December 31, 2020. We compared the positivity rate of conventional microbiologic diagnostic testing with that of cfNGS and the impact on clinical management, including changes in antibiotic therapy.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>We identified 46 hospitalized children with cCAP with cfNGS results. Of these children, 34 also had blood cultures (1 positive for pathogen; 3%) and 37 had pleural fluid cultures (10 positive for pathogen; 27%). Of the 46 children, positive cfNGS testing results were positive for pathogen in 45 (98%), with the causative pathogen identified in 41 (89%). cfNGS was the only method for pathogen identification in 32 children (70%). cfNGS results changed management in 36 (78%) of 46 children, with the antibiotic spectrum narrowed in 29 (81%).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>cfNGS provided a higher diagnostic yield in our pediatric cCAP cohort compared with conventional diagnostic testing and affected management in 78% of children. Prospective studies are needed to better characterize the clinical outcome, cost-effectiveness, and antimicrobial stewardship benefits of cfNGS in pediatric cCAP.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1542\/hpeds.2021-006361","type":"journal-article","created":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T08:05:58Z","timestamp":1646208358000},"page":"377-384","source":"Crossref","is-referenced-by-count":20,"title":["Impact of Cell-Free Next-Generation Sequencing on Management of Pediatric Complicated Pneumonia"],"prefix":"10.1542","volume":"12","author":[{"given":"Zephyr D.","family":"Dworsky","sequence":"first","affiliation":[{"name":"1aDepartment of Pediatrics, University of California, San Diego, San Diego, California"},{"name":"bRady Children\u2019s Hospital, San Diego, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Begem","family":"Lee","sequence":"additional","affiliation":[{"name":"1aDepartment of Pediatrics, University of California, San Diego, San Diego, California"},{"name":"bRady Children\u2019s Hospital, San Diego, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanda","family":"Ramchandar","sequence":"additional","affiliation":[{"name":"1aDepartment of Pediatrics, University of California, San Diego, San Diego, California"},{"name":"bRady Children\u2019s Hospital, San Diego, California"},{"name":"cDepartment of Pediatrics, Naval Medical Center San Diego, San Diego, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiranun","family":"Rungvivatjarus","sequence":"additional","affiliation":[{"name":"1aDepartment of Pediatrics, University of California, San Diego, San Diego, California"},{"name":"bRady Children\u2019s Hospital, San Diego, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole G.","family":"Coufal","sequence":"additional","affiliation":[{"name":"1aDepartment of Pediatrics, University of California, San Diego, San Diego, California"},{"name":"bRady Children\u2019s Hospital, San Diego, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John S.","family":"Bradley","sequence":"additional","affiliation":[{"name":"1aDepartment of Pediatrics, University of California, San Diego, San Diego, California"},{"name":"bRady Children\u2019s Hospital, San Diego, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2022,3,2]]},"reference":[{"issue":"1","key":"2022040102571092000_b1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.idc.2017.11.002","article-title":"Pediatric community-acquired pneumonia in the United States: changing epidemiology, diagnostic and therapeutic challenges, and areas for future research","volume":"32","author":"Katz","year":"2018","journal-title":"Infect Dis Clin North Am"},{"key":"2022040102571092000_b2","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/B978-1-4377-2702-9.00034-9","article-title":"Acute pneumonia and its complications","author":"Mani","year":"2012","journal-title":"Principles and Practice of Pediatric Infectious Diseases"},{"issue":"4","key":"2022040102571092000_b3","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2174\/1574887112666170816144110","article-title":"Management of complicated pneumonia in childhood: a review of recent literature","volume":"12","author":"Darby","year":"2017","journal-title":"Rev Recent Clin Trials"},{"issue":"2","key":"2022040102571092000_b4","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1542\/peds.2009-3109","article-title":"National hospitalization trends for pediatric pneumonia and associated complications","volume":"126","author":"Lee","year":"2010","journal-title":"Pediatrics"},{"issue":"7","key":"2022040102571092000_b5","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1093\/cid\/cir531","article-title":"The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America","volume":"53","author":"Bradley","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"7","key":"2022040102571092000_b6","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.cmi.2018.10.020","article-title":"Changes in the incidence and bacterial aetiology of paediatric parapneumonic pleural effusions\/empyema in Germany, 2010-2017: a nationwide surveillance study","volume":"25","author":"Liese","year":"2019","journal-title":"Clin Microbiol Infect"},{"issue":"20","key":"2022040102571092000_b7","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1016\/j.vaccine.2019.04.012","article-title":"Significant impact of pneumococcal conjugate vaccination on pediatric parapneumonic effusion: Italy 2006-2018","volume":"37","author":"Azzari","year":"2019","journal-title":"Vaccine"},{"issue":"2","key":"2022040102571092000_b8","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/ppul.23523","article-title":"Complicated community acquired pneumonia in childhood: Different types, clinical course, and outcome","volume":"52","author":"Erlichman","year":"2017","journal-title":"Pediatr Pulmonol"},{"issue":"4","key":"2022040102571092000_b9","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/s41564-018-0349-6","article-title":"Analytical and clinical validation of a microbial cell-free DNA sequencing test for infectious disease","volume":"4","author":"Blauwkamp","year":"2019","journal-title":"Nat Microbiol"},{"key":"2022040102571092000_b10","article-title":"Plasma microbial cell-free DNA next generation sequencing in the diagnosis and management of febrile neutropenia [published online ahead of print on April 19, 2021]","author":"Benamu","journal-title":"Clin Infect Dis"},{"issue":"5","key":"2022040102571092000_b11","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/INF.0000000000003038","article-title":"Use of plasma metagenomic next-generation sequencing for pathogen identification in pediatric endocarditis","volume":"40","author":"To","year":"2021","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"2022040102571092000_b12","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.diagmicrobio.2018.12.016","article-title":"Community-acquired pneumonia in children: cell-free plasma sequencing for diagnosis and management","volume":"94","author":"Farnaes","year":"2019","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"2","key":"2022040102571092000_b13","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/cid\/ciaa035","article-title":"Clinical impact of metagenomic next-generation sequencing of plasma cell-free DNA for the diagnosis of infectious diseases: a multicenter retrospective cohort study","volume":"72","author":"Hogan","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"3","key":"2022040102571092000_b14","doi-asserted-by":"crossref","first-page":"e20171013","DOI":"10.1542\/peds.2017-1013","article-title":"Utility of blood culture among children hospitalized with community-acquired pneumonia","volume":"140","author":"Neuman","year":"2017","journal-title":"Pediatrics"},{"issue":"10","key":"2022040102571092000_b15","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1542\/hpeds.2019-0149","article-title":"Predictors of bacteremia in children hospitalized with community-acquired pneumonia","volume":"9","author":"Lipsett","year":"2019","journal-title":"Hosp Pediatr"},{"issue":"5","key":"2022040102571092000_b16","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1086\/338642","article-title":"Etiological diagnosis of childhood pneumonia by use of transthoracic needle aspiration and modern microbiological methods","volume":"34","author":"Vuori-Holopainen","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"4","key":"2022040102571092000_b17","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1086\/338460","article-title":"An epidemiological investigation of a sustained high rate of pediatric parapneumonic empyema: risk factors and microbiological associations","volume":"34","author":"Byington","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"6","key":"2022040102571092000_b18","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/INF.0000000000003036","article-title":"Effect of prehospital antibiotic therapy on clinical outcome and pathogen detection in children with parapneumonic pleural effusion\/pleural empyema","volume":"40","author":"Forster","year":"2021","journal-title":"Pediatr Infect Dis J"},{"issue":"8","key":"2022040102571092000_b19","doi-asserted-by":"crossref","first-page":"ofz327","DOI":"10.1093\/ofid\/ofz327","article-title":"Noninvasive diagnosis of infection using plasma next-generation sequencing: a single-center experience","volume":"6","author":"Rossoff","year":"2019","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"2022040102571092000_b20","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1186\/s12879-021-06292-4","article-title":"Clinical application of cell-free next-generation sequencing for infectious diseases at a tertiary children\u2019s hospital","volume":"21","author":"Wilke","year":"2021","journal-title":"BMC Infect Dis"},{"key":"2022040102571092000_b21","article-title":"Microbial cell-free DNA identifies etiology of bloodstream infections, persists longer than conventional blood cultures, and its duration of detection is associated with metastatic infection in patients with Staphylococcus aureus and Gram-negative bacteremia [published online ahead of print on August 30, 2021]","author":"Eichenberger","journal-title":"Clin Infect Dis"}],"container-title":["Hospital Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/hospitalpediatrics\/article-pdf\/12\/4\/377\/1275577\/hpeds.2021-006361.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/hospitalpediatrics\/article-pdf\/12\/4\/377\/1275577\/hpeds.2021-006361.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T02:57:49Z","timestamp":1648781869000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/hospitalpediatrics\/article\/12\/4\/377\/185228\/Impact-of-Cell-Free-Next-Generation-Sequencing-on"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,2]]},"references-count":21,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,3,2]]},"published-print":{"date-parts":[[2022,4,1]]}},"URL":"https:\/\/doi.org\/10.1542\/hpeds.2021-006361","relation":{},"ISSN":["2154-1663","2154-1671"],"issn-type":[{"value":"2154-1663","type":"print"},{"value":"2154-1671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,2]]}}}